WILMINGTON, Mass., Jan. 26, 2022 /PRNewswire/ — CuriRx, Inc., a leading contract development and manufacturing organization (CDMO), announced today the launch of the Advanced Bioprocessing and […]
Join CuriRx for a complimentary Lunch & Learn! CuriLytics™: De-risking CMC characterization by using high resolution mass spectrometry Date: Tuesday, November 9th Time: 12:00-1:00pm Place: MassBio […]
WILMINGTON, Mass., Sept. 21, 2021 /PRNewswire/ CuriRx, Inc., a leading contract research (CRO) and product development organization, announced today the launch of their new CuriLytics™ platform with […]